Study: Polypill linked to lower risk of heart disease

01/18/2013 | Capital Times (Madison, Wis.), The

A polypill that includes aspirin, a statin and three blood pressure lowering drugs could lower the lifetime risk of heart disease by 21% in men and 15% in women, a study in Latin America found. The polypill "would be cost-effective and could also be cost-saving," study leader Leonelo Bautista said. The study was published in the journal Health Affairs.

View Full Article in:

Capital Times (Madison, Wis.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC